CRISPR Therapeutics AG (CRSP) Asset Utilization Ratio (2016 - 2026)
CRISPR Therapeutics AG's Asset Utilization Ratio came in at 0.00 for Q2 2026, down 72.5% from 0.02 a year earlier but up 203.0% from the prior quarter.
Powered by 
Analysis
CRISPR Therapeutics AG (CRSP) Asset Utilization Ratio (2016 - 2026) Analysis & Trends
Going back to Q4 2016, CRISPR Therapeutics AG's Asset Utilization Ratio data covers 39 quarters.
- Going back by year, Asset Utilization Ratio was 0.02 in FY2024 (-89.9%), 0.17 in FY2023, 0.00 in FY2022 (-99.9%) and 0.40 in FY2021.
- The five-year range for quarterly Asset Utilization Ratio is 0.00 (Q4 2022) to 0.34 (Q1 2022).
- Year-over-year, Asset Utilization Ratio has declined for seven consecutive quarters, with an average decline of 72.0% over the last eight quarters.
- The fastest year-over-year change in Asset Utilization Ratio over five years came in Q3 2021 (growth of 416.1%), and the weakest in Q4 2022 (a decline of 99.8%).
- Business Quant data shows CRSP's Asset Utilization Ratio at 0.00 (Q1 2026), 0.00 (Q4 2025) and 0.02 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 0.31 |
| 10 | CRISPR Therapeutics AG | 4.88 Bn | -3.82 Bn | - | 0.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00 |
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | 0.00 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.02 |
| Mar 31, 2025 | 0.02 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.09 |
| Jun 30, 2024 | 0.08 |
| Mar 31, 2024 | 0.12 |
| Dec 31, 2023 | 0.17 |
| Sep 30, 2023 | 0.08 |
| Jun 30, 2023 | 0.08 |
| Mar 31, 2023 | 0.04 |
| Dec 31, 2022 | 0.00 |
| Sep 30, 2022 | 0.01 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.33 |
| Sep 30, 2021 | 0.32 |
API Access
CRISPR Therapeutics AG Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CRSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();